• Create the Future to Overcome Cancer

 


News

2026/05/20
Seminar Presentation at INTERPHEX WEEK TOKYO 2026 / Regenerative Medicine Expo Tokyo 2026

Noile-Immune is pleased to announce that our President & CEO, Koji Tamada, MD, Ph.D. (Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine/ Director, Research Institute for Cell Design Medical Science, Yamaguchi University), delivered a presentation on the latest trends in next-generation CAR-T therapies and their prospects for social implementation at a seminar held during INTERPHEX WEEK TOKYO 2026 / Regenerative Medicine Expo Tokyo 2026 (from Wednesday, May 20 to Friday, May 22, 2026 at Makuhari Messe in Chiba City).


2026/05/13
Our Position Regarding the Matter Disclosed by Takara Bio Inc.
2026/04/21
Development of Next-Generation T-Cell Gene Editing Technology Using CRISPR-Cas3
2026/03/24
Mie Television featured Noile-Immune Biotech in the “Insight Monthly”, a corner of “Okasan Investment Navi” as a “company aiming to overcome cancer through the immune system” (Information updated on April 2, 2026).
---------------------------------------------------
“Okasan Investment Navi”, Mie Television Broadcasting Co., Ltd.
  • Episode 1: Aired on March 7, 2026
  • Episode 2: Aired on March 14, 2026
  • Episode 3: Aired on March 21, 2026
  • Episode 4: Aired on March 28, 2026
 Interview by Ryota Watanabe
---------------------------------------------------

2026/03/23
Seminar Presentation at 25th Annual Meeting of the Japanese Society for Regenerative Medicine as Co-sponsored Scientific Seminar

We are pleased to announce that Dr. Koji Tamada, President and CEO of our company (Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine; Director, Research Institute for Cell Design Medical Science), served as the session chair, and Dr. Akihiko Yoshimura, Professor in the Division of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science and also an advisor to our company, delivered a presentation on advances in CAR-T cell technology at the Co-sponsored Scientific Seminar (Luncheon Seminar 20, co-sponsored by Hitachi, Ltd.) held during the 25th Annual Meeting of the Japanese Society for Regenerative Medicine (March 19–20, 2026, Kobe International Conference Center and Kobe International Exhibition Hall).